Cargando…
Does the cytokine adsorber CytoSorb(®) reduce vancomycin exposure in critically ill patients with sepsis or septic shock? a prospective observational study
BACKGROUND: Hemadsorption of cytokines is used in critically ill patients with sepsis or septic shock. Concerns have been raised that the cytokine adsorber CytoSorb(®) unintentionally adsorbs vancomycin. This study aimed to quantify vancomycin elimination by CytoSorb(®). METHODS: Critically ill pati...
Autores principales: | Scharf, Christina, Weinelt, Ferdinand, Schroeder, Ines, Paal, Michael, Weigand, Michael, Zoller, Michael, Irlbeck, Michael, Kloft, Charlotte, Briegel, Josef, Liebchen, Uwe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124739/ https://www.ncbi.nlm.nih.gov/pubmed/35599248 http://dx.doi.org/10.1186/s13613-022-01017-5 |
Ejemplares similares
-
No clinically relevant removal of meropenem by cytokine adsorber CytoSorb(®) in critically ill patients with sepsis or septic shock
por: Liebchen, Uwe, et al.
Publicado: (2021) -
Can the cytokine adsorber CytoSorb(®) help to mitigate cytokine storm and reduce mortality in critically ill patients? A propensity score matching analysis
por: Scharf, Christina, et al.
Publicado: (2021) -
CytoSorb® Hemoadsorption as a Promising Tool to Handle COVID-19-Induced Cytokine Storm
por: Acevedo, Alice-Christin, et al.
Publicado: (2021) -
CytoSorb-friend or foe!!
por: Pattnaik, Saroj Kumar, et al.
Publicado: (2015) -
The cytokine adsorber Cytosorb® does not reduce ammonia concentrations in critically ill patients with liver failure
por: Liebchen, Uwe, et al.
Publicado: (2023)